NASDAQ:NUWE Nuwellis (NUWE) Stock Price, News & Analysis $0.69 +0.01 (+2.06%) Closing price 04:00 PM EasternExtended Trading$0.68 -0.01 (-1.60%) As of 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsNews and TrendsOwnershipSEC Filings About Nuwellis Stock (NASDAQ:NUWE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nuwellis alerts:Sign Up Key Stats Today's Range$0.67▼$0.7150-Day Range$0.68▼$1.8852-Week Range$0.67▼$172.90Volume149,999 shsAverage Volume1.48 million shsMarket Capitalization$2.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Nuwellis, Inc. is a medical device company focused on treating patients with fluid overload associated with heart failure and other conditions. The company’s technology is designed to remove excess salt and fluid from the body through ultrafiltration, offering an alternative or complement to conventional diuretic therapy. Nuwellis’ principal product is the Aquadex system, a compact ultrafiltration platform used in hospital and clinical settings. The system includes a console, blood circuit and specialized catheter components, and is intended to help healthcare professionals manage fluid overload in patients who may not respond adequately to diuretics. The company was formerly known as CHF Solutions, Inc. and adopted the Nuwellis name in 2020. Its products are marketed primarily to healthcare providers in the United States, with the company focused on expanding the use of ultrafiltration in the management of cardiorenal disease. Nuwellis is headquartered in Minneapolis, Minnesota.AI Generated. May Contain Errors. Read More Nuwellis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreNUWE MarketRank™: Nuwellis scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingNuwellis has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNuwellis has only been the subject of 1 research reports in the past 90 days.Read more about Nuwellis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Nuwellis is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nuwellis is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNuwellis has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Nuwellis' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.67% of the float of Nuwellis has been sold short.Short Interest Ratio / Days to CoverNuwellis has a short interest ratio ("days to cover") of 0.03, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nuwellis has recently increased by 339.57%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNuwellis does not currently pay a dividend.Dividend GrowthNuwellis does not have a long track record of dividend growth. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Nuwellis this week, compared to 2 articles on an average week.Search Interest1 people have searched for NUWE on MarketBeat in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nuwellis insiders have not sold or bought any company stock.Percentage Held by Insiders1.60% of the stock of Nuwellis is held by insiders.Percentage Held by Institutions3.13% of the stock of Nuwellis is held by institutions.Read more about Nuwellis' insider trading history. Receive NUWE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NUWE Stock News HeadlinesNuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT SystemOctober 8 at 8:30 AM | globenewswire.comNuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical ConferencesOctober 1, 2026 | globenewswire.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.October 9 at 1:00 AM | Investors Alley (Ad)Nuwellis Appoints Brian Johnson As Director Of Quality And Regulatory AffairsSeptember 17, 2026 | rttnews.comNuwellis reports 31 Aquadex console sales in 2026, expanding recurring revenue opportunitySeptember 17, 2026 | msn.comNuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue OpportunitySeptember 17, 2026 | globenewswire.comNuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory AffairsSeptember 16, 2026 | globenewswire.comNuwellis Advances Financial Efficiency Strategy with Improved Gross MarginsSeptember 9, 2026 | globenewswire.comSee More Headlines NUWE Stock Analysis - Frequently Asked Questions How have NUWE shares performed this year? Nuwellis' stock was trading at $60.90 at the start of the year. Since then, NUWE stock has decreased by 98.9% and is now trading at $0.6890. How were Nuwellis' earnings last quarter? Nuwellis, Inc. (NASDAQ:NUWE) released its quarterly earnings data on Thursday, August, 13th. The company reported ($26.64) EPS for the quarter, missing the consensus estimate of ($23.80) by $2.84. The company earned $1.97 million during the quarter, compared to the consensus estimate of $2.42 million. Nuwellis had a negative trailing twelve-month return on equity of 623.14% and a negative net margin of 123.38%. Read the conference call transcript. When did Nuwellis' stock split? Nuwellis's stock reverse split on Friday, June 28th 2024.The 1-35 reverse split was announced on Friday, June 28th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Nuwellis? Shares of NUWE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nuwellis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nuwellis investors own include TransCode Therapeutics (RNAZ), Exela Technologies (XELA), AMC Entertainment (AMC), BIOLASE (BIOL) and Company Calendar Last Earnings8/13/2026Today10/09/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (4m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 NUWE's financial health is in the Red zone, according to TradeSmith. NUWE has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NUWE CIK1506492 Webwww.nuwellis.com Phone(952) 345-4200FaxN/AEmployees38Year FoundedN/AProfitability EPS (Trailing Twelve Months)($132.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$17.52 million Net Margins-123.38% Pretax Margin-125.63% Return on Equity-623.14% Return on Assets-147.34% Debt Debt-to-Equity RatioN/A Current Ratio1.97 Quick Ratio1.54 Sales & Book Value Annual Sales$9.01 million Price / Sales0.28 Cash FlowN/A Price / Cash FlowN/A Book Value$55.31 per share Price / Book0.01Miscellaneous Outstanding Shares3,647,000Free Float3,589,000Market Cap$2.51 million OptionableNot Optionable Beta0.09 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:NUWE) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersYou Won’t Get a Warning Before This Correction HitsGold just broke another record - a classic flight-to-safety signal that the smartest money on Wall Street is a...StockEarnings | SponsoredThe $8,000 Gold Call Every Retirement Saver Needs to Read Right NowGold didn't creep higher—it broke $5,000, a level many analysts thought would hold. Now JPMorgan, the biggest ...Golden Crest Metals | SponsoredWhy The Biggest Names in AI Are Heading To The ArcticGoogle contracted over 12 GW of energy last year and just announced a 15 billion dollar AI infrastructure inve...The Tomorrow Investor | Sponsored25 candidates screened. 5 made it.More than 25 candidates were screened for share price between $1 and $5, market cap above $100 million, daily ...TradingTips | SponsoredNo complicated options contracts. No specialized trading accountsA simple morning routine could put around $500 in play on a $1,000 stake in under an hour, using nothing but a...ProsperityPub | SponsoredElon just declared war on your phoneSpaceX reportedly agreed to pay 8 billion dollars for a major slice of U.S. wireless spectrum, and shares of A...Stansberry Research | SponsoredTomorrow morning's stock alertOur research analysts are set to release their next stock idea tomorrow morning just before 12:00 PM Eastern. ...The Early Bird | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
